From collecting and analysis of the clinical data of pancreatic cancer patients, we found that Girdin was overexpressed in pancreatic cancer and higher expression of Girdin was associated with tumor size and TNM stage. This evidence concerns the gene CCDC88A and pancreatic neoplasm.